Referring to cancer as a “battle” minimizes the many real issues faced by cancer patients who must live with nausea, pain, ...

West Philadelphia native Fran Visco, who heads the National Breast Cancer Coalition, is feted at White House. When Fran Visco ...

It’s been months in the making, but now the new resource is available for those battling the treatable, but incurable form of ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The exciting findings that we're presenting in the poster ...

It felt suffocating at first. I was suddenly in a hospital bed, with metastatic cancer up and down my bones, across both lungs, in my brain. I desperately wanted to find other cancer patients who ...

For many, these challenges become even more complex when cancer spreads to other body parts, such as the spine. Metastatic spine ... prostate, and breast are most likely to affect the vertebral ...

The authors have assembled comprehensive datasets from various subtypes of localized and lung-metastatic breast cancer cells, as well as from healthy and cancerous lung cells. They identified ...

In February 2024, the agent was granted fast track designation from the FDA as a monotherapy for the treatment of adult patients with ER+/HER2- locally advanced or metastatic breast cancer that ...

FDA approved Braftovi, Erbitux, and mFOLFOX6 for BRAF V600E mutation-positive metastatic colorectal cancer. BREAKWATER trial showed a 61% objective response rate for the treatment group versus 40% for ...

Addition of the CDK 4/6 inhibitor improved progression-free survival by 15.2 months for patients with HR-positive/HER2-positive advanced breast cancer.